This study showed that HCG18 expression was elevated in both HNSCC patient tissues and cell lines, and the expression of HCG18 was positively correlated with OS and lymph node metastasis, indicating that HNSCC patients with higher HCG18 expression levels had poorer clinical outcomes. This evidence concerns the gene HCG18 and head and neck squamous cell carcinoma.